FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2972606225> ?p ?o ?g. }

• W2972606225 endingPage "726" @default.
• W2972606225 startingPage "718" @default.
• W2972606225 abstract "Abstract Objective To assess the safety and efficacy of glucocorticoids (GCs), immunosuppressive agents (IM) and rituximab (RTX), alone or in combination, for the treatment of IgG4-RD. Methods Relevant articles published were searched in the databases with relevant key words. Network meta-analysis was conducted, with various outcomes including relapse rate, remission rate and adverse events. Data were calculated with odds ratio (ORs) and 95% CI. P-score was used to rank the treatments. Results A total of 15 studies involving 1169 patients were included. Network meta-analysis indicated that RTX maintenance therapy had the lowest relapse rate of all treatments (OR = 0.10, 95% CI [0.01, 1.63]), whereas GCs + IM was associated with a lower relapse rate compared with GCs alone (OR = 0.39, 95% CI [0.20, 0.80]). Further, patients treated with GCs + IM had a higher remission rate than those given GCs (OR= 3.36, 95% CI [1.44, 7.83]), IM (OR= 55.31, 95% CI [13.73, 222.73]) monotherapies or RTX induction therapy only (OR= 7.38, 95% CI [1.56, 34.94]). The rate of adverse events was comparable among the different treatment groups. Conclusion Treatment of IgG4-RD patients with GCs and IM was associated with higher remission rates and lower relapse rates, as well as comparable safety profiles compared with GC, IM and RTX induction therapy. RTX maintenance therapy had a larger reduction in the relapse rate compared with GC and IM. The current evidence should be carefully scrutinized as the included studies were observational in design. Larger randomized controlled trials are needed to confirm." @default.
• W2972606225 created "2019-09-19" @default.
• W2972606225 creator A5037506720 @default.
• W2972606225 creator A5039645917 @default.
• W2972606225 creator A5046840576 @default.
• W2972606225 creator A5071942431 @default.
• W2972606225 date "2019-09-11" @default.
• W2972606225 modified "2023-10-16" @default.
• W2972606225 title "Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis" @default.
• W2972606225 cites W113269428 @default.
• W2972606225 cites W1617328014 @default.
• W2972606225 cites W1853735554 @default.
• W2972606225 cites W1971271788 @default.
• W2972606225 cites W1979423827 @default.
• W2972606225 cites W1995777506 @default.
• W2972606225 cites W2019122570 @default.
• W2972606225 cites W2026711372 @default.
• W2972606225 cites W2042567949 @default.
• W2972606225 cites W2046297453 @default.
• W2972606225 cites W2066618031 @default.
• W2972606225 cites W2069863449 @default.
• W2972606225 cites W2100918713 @default.
• W2972606225 cites W2102254061 @default.
• W2972606225 cites W2108302885 @default.
• W2972606225 cites W2111999709 @default.
• W2972606225 cites W2116475791 @default.
• W2972606225 cites W2139500303 @default.
• W2972606225 cites W2150120272 @default.
• W2972606225 cites W2192872568 @default.
• W2972606225 cites W2274046219 @default.
• W2972606225 cites W2509094418 @default.
• W2972606225 cites W2518504487 @default.
• W2972606225 cites W2549318420 @default.
• W2972606225 cites W2602321390 @default.
• W2972606225 cites W2610128427 @default.
• W2972606225 cites W2619962134 @default.
• W2972606225 cites W2758287922 @default.
• W2972606225 cites W2789924474 @default.
• W2972606225 cites W2790090724 @default.
• W2972606225 cites W2792613800 @default.
• W2972606225 cites W2803022162 @default.
• W2972606225 cites W2803071988 @default.
• W2972606225 cites W2888152279 @default.
• W2972606225 cites W2904061134 @default.
• W2972606225 cites W3140754719 @default.
• W2972606225 cites W4252135493 @default.
• W2972606225 doi "https://doi.org/10.1093/rheumatology/kez380" @default.
• W2972606225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31511884" @default.
• W2972606225 hasPublicationYear "2019" @default.
• W2972606225 type Work @default.
• W2972606225 sameAs 2972606225 @default.
• W2972606225 citedByCount "37" @default.
• W2972606225 countsByYear W29726062252020 @default.
• W2972606225 countsByYear W29726062252021 @default.
• W2972606225 countsByYear W29726062252022 @default.
• W2972606225 countsByYear W29726062252023 @default.
• W2972606225 crossrefType "journal-article" @default.
• W2972606225 hasAuthorship W2972606225A5037506720 @default.
• W2972606225 hasAuthorship W2972606225A5039645917 @default.
• W2972606225 hasAuthorship W2972606225A5046840576 @default.
• W2972606225 hasAuthorship W2972606225A5071942431 @default.
• W2972606225 hasBestOaLocation W29726062251 @default.
• W2972606225 hasConcept C126322002 @default.
• W2972606225 hasConcept C156957248 @default.
• W2972606225 hasConcept C197934379 @default.
• W2972606225 hasConcept C2776999253 @default.
• W2972606225 hasConcept C2779338263 @default.
• W2972606225 hasConcept C2780653079 @default.
• W2972606225 hasConcept C38652104 @default.
• W2972606225 hasConcept C41008148 @default.
• W2972606225 hasConcept C71924100 @default.
• W2972606225 hasConcept C79736992 @default.
• W2972606225 hasConcept C90924648 @default.
• W2972606225 hasConcept C95190672 @default.
• W2972606225 hasConceptScore W2972606225C126322002 @default.
• W2972606225 hasConceptScore W2972606225C156957248 @default.
• W2972606225 hasConceptScore W2972606225C197934379 @default.
• W2972606225 hasConceptScore W2972606225C2776999253 @default.
• W2972606225 hasConceptScore W2972606225C2779338263 @default.
• W2972606225 hasConceptScore W2972606225C2780653079 @default.
• W2972606225 hasConceptScore W2972606225C38652104 @default.
• W2972606225 hasConceptScore W2972606225C41008148 @default.
• W2972606225 hasConceptScore W2972606225C71924100 @default.
• W2972606225 hasConceptScore W2972606225C79736992 @default.
• W2972606225 hasConceptScore W2972606225C90924648 @default.
• W2972606225 hasConceptScore W2972606225C95190672 @default.
• W2972606225 hasFunder F4320321001 @default.
• W2972606225 hasIssue "4" @default.
• W2972606225 hasLocation W29726062251 @default.
• W2972606225 hasLocation W29726062252 @default.
• W2972606225 hasOpenAccess W2972606225 @default.
• W2972606225 hasPrimaryLocation W29726062251 @default.
• W2972606225 hasRelatedWork W152659163 @default.
• W2972606225 hasRelatedWork W2029951657 @default.
• W2972606225 hasRelatedWork W2154169709 @default.
• W2972606225 hasRelatedWork W2265981062 @default.
• W2972606225 hasRelatedWork W2286371484 @default.
• W2972606225 hasRelatedWork W2411583971 @default.

• next